Mepolizumab in severe asthma exacerbation in a respiratory ICU¿a successful off-label use H.C. Rodrigues; C. Martins; E. Fragoso; C. Lopes; P. Azevedo;

Efficacy of elexacaftor-tezacaftor-ivacaftor in portuguese adolescents and adults with cystic fibrosis carrying non-F508del variants M.O. Pinto; A.S. Santos; S. Castanhinha;

Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors M. Serino; C. Freitas; M. Martins; P. Ferreira; C. Cardoso; F. Veiga; V. Santos; D. Araújo; H. Novais-Bastos; A. Magalhães; H. Queiroga; G. Fernandes; V. Hespanhol;